News
The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value ...
Vietnam Investment Review on MSN2d
XellSmart gains FDA clearance for three iPSC cell therapiesXellSmart has completed multiple cases of iPSC-derived dopaminergic neural progenitor cell therapy for patients with ...
Explore the functional analysis of compound responses in iPSC-derived 3D cardiac microtissues for insights into cardiac ...
GlobalData on MSN16h
Axxam and Molecular Health link for therapeutic targetsThe partnership will integrate Molecular Health’s digital drug development platform into Axxam's integrated early drug ...
SUZHOU, China, June 2, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell ...
Independent.ie on MSN19h
Trinity College Dublin to divest from links with Israeli universities and firmsTrinity College Dublin is to divest from new arrangements with Israeli universities, firms and institutions. The board of the ...
SUZHOU, China, June 3, 2025 /PRNewswire/ --XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell ...
Highlights the unique potential of Celularity’s proprietary advanced biomaterial technology as a novel cellular delivery system for ocular surface reconstructionSupports broad range of regenerative ...
Japan’s foray into regenerative medicine takes on added importance for a nation wrestling with age, stagnation, and its place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback